Capillary Technologies' Market Debut: A Look Beyond the Initial Dip
Share- Nishadil
- November 21, 2025
- 0 Comments
- 4 minutes read
- 0 Views
Well, sometimes the market has a funny way of dashing expectations, doesn't it? Such seems to be the story for Capillary Technologies, an AI-powered customer loyalty and engagement solutions provider, whose shares recently made their debut on the Bombay Stock Exchange (BSE). Despite a healthy buzz in the grey market, the company's stock opened its trading journey with a rather modest performance, listing at a noticeable discount to its initial public offering (IPO) price.
Specifically, Capillary Technologies' shares kicked off trading at Rs 263.30 apiece on Thursday, March 28, 2024. Now, if you do the quick math, that's a roughly 3 percent dip compared to the IPO's upper price band of Rs 280 per share. The issue price, you see, was fixed between Rs 269 and Rs 280, with a midpoint of Rs 274.50. So, no matter how you slice it, a debut below even the lower end of that range certainly wasn't the roaring start many might have hoped for.
The real kicker here, and what probably stung many early birds, was the significant discrepancy with the grey market. Before the listing, Capillary Technologies’ unlisted shares were reportedly commanding a premium of around Rs 50-55. This Grey Market Premium (GMP) had hinted at a potential listing gain of a robust 18-20 percent! One can only imagine the collective shrug, or perhaps even a wince, from those who followed the grey market signals, only to see the shares open in the red instead of soaring.
So, what exactly is Capillary Technologies all about? At its core, the company specializes in crafting AI-powered software solutions designed to help businesses, particularly those in retail and hospitality, build and nurture customer loyalty. They're all about engagement, retention, and really understanding what makes a customer tick. Think of it as the brain behind those loyalty programs and personalized offers we all encounter.
The IPO itself was quite substantial, totaling Rs 371 crore. This was a mix of a fresh issue of Rs 200 crore – money going directly into the company's coffers – and an Offer for Sale (OFS) of Rs 171 crore, where existing shareholders offloaded some of their holdings. The funds raised from the fresh issue were earmarked for several strategic purposes: paying down borrowings, shoring up working capital, investing in product development, and handling general corporate needs. Sensible stuff, really.
Looking at the company's financials, there's been an interesting shift. While Capillary Technologies reported losses in earlier fiscal years (FY21, FY22, and even the first half of FY23), they managed to turn a corner. They posted a profit of Rs 7 crore for the full fiscal year 2023 and continued that positive trend with a profit of Rs 5.2 crore in the first half of FY24. Revenue has also shown a healthy upward trajectory. This swing from loss to profit makes the subdued listing all the more intriguing, suggesting investors might be taking a "wait and see" approach despite the improved bottom line.
The IPO was managed by some big names in the financial world: Nuvama Wealth Management and IIFL Securities acted as the book-running lead managers, while Link Intime India Private was the registrar. They certainly had their work cut out for them, navigating the market sentiments around this tech-driven offering.
Ultimately, Capillary Technologies’ market debut serves as a stark reminder that even with promising technology, improving financials, and optimistic grey market predictions, the actual day of listing can still hold surprises. For now, it seems investors are keeping a close eye on this AI loyalty powerhouse, perhaps waiting for the initial market jitters to subside before fully embracing its potential.
Disclaimer: This article was generated in part using artificial intelligence and may contain errors or omissions. The content is provided for informational purposes only and does not constitute professional advice. We makes no representations or warranties regarding its accuracy, completeness, or reliability. Readers are advised to verify the information independently before relying on